Ten-year findings suggest some patients may safely receive less treatment, potentially lowering side effects without raising ...
Effect of neutropenia with adjuvant epirubicin-CMF on survival in patients with node-negative or 1 to 3 node-positive rapidly proliferating breast cancer. This is an ASCO Meeting Abstract from the ...
What to Expect ...